Global Eye Infections Growth Rate 2025, Forecast To 2034
26 Mar, 2025
What Is The Current and Historic Market Size Analysis Of The Eye Infections Market?
The eye infections market has seen considerable growth due to a variety of factors.
• The market for eye infections has seen a steady rise over the past few years. The growth is projected to continue, with its value increasing from $7.53 billion in 2024 to $7.96 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%.
The market's growth during the historical period is a result of factors such as increased exposure to pollutants that lead to eye irritation, a higher frequency of eye infections in children, an uptick in medical tourism related to eye surgeries, a rising demand for combination therapies for more complicated infections, and a rise in cases of allergic conjunctivitis.
What are the Market Size and Expected Growth Rates for the Eye Infections Market?
The eye infections market is expected to maintain its strong growth trajectory in upcoming years.
• There is forecasted to be substantial expansion in the market for eye infections, which is predicted to escalate to $9.83 billion by 2029, at a compound annual growth rate (CAGR) of 5.4%.
This projected growth across the forecast period can be accounted for by an escalating incidence of eye infections, an aging population susceptible to eye complaints, a rise in diabetic cases affecting eye wellness, an upsurge in contact lens-related infections, and enhanced knowledge of eye health significance. Key trends materializing during the forecast period encompass progress in diagnostic technologies for eye infections, artificial intelligence-backed diagnostic mechanisms for eye conditions, the use of 3D printing technology in ophthalmology treatments, the advent of genetically tailored therapies for uncommon eye infections, and refined antibiotics and antivirals.
Which Key Drivers Are Propelling The Eye Infections Market's Growth?
The escalating occurrence and frequency of disorders related to the eye is projected to boost the market for eye infections. These eye-related disorders consist of various conditions impacting the eye, including illnesses like glaucoma, cataracts, macular degeneration, as well as refractive issues like myopia and hyperopia. The surge in patients suffering from eye-related disorders can be attributed to factors such as aging populations, alterations in lifestyles, environmental elements, and shortcomings in diagnostic abilities leading to a postponement in detecting problems. Eye infections can exacerbate or lead to the onset of eye-related disorders by instigating inflammation, tissue harm, and damaging the eye's innate defenses. This could eventually result in complications like loss of vision or chronic ailments. For example, in October 2024, as per the World Health Organization, a health authority based in Switzerland, in 2023, 130,746 people underwent surgery for advanced trachoma, and 32.9 million received antibiotics, yielding a global coverage of 29%. Hence, the rising occurrence and prevalence of disorders related to the eye are set to propel the market for eye infections going forward.
What Are The Key Segments Within The Global Eye Infections Market?
The eye infections market covered in this report is segmented –
1) By Indications: Conjunctivitis, Keratitis, Endophthalmitis, Blepharitis, Stye, Uveitis, Cellulitis, Ocular Herpes
2) By Drug Type: Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Conjunctivitis: Bacterial Conjunctivitis, Viral Conjunctivitis, Allergic Conjunctivitis
2) By Keratitis: Bacterial Keratitis, Viral Keratitis, Fungal Keratitis, Acanthamoeba Keratitis
3) By Endophthalmitis: Post-surgical Endophthalmitis, Post-traumatic Endophthalmitis, Endogenous Endophthalmitis
4) By Blepharitis: Anterior Blepharitis, Posterior Blepharitis
5) By Stye: Internal Stye, External Stye
6) By Uveitis: Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Panuveitis
7) By Cellulitis: Periorbital Cellulitis, Orbital Cellulitis
8) By Ocular Herpes: Herpes Simplex Keratitis, Herpes Simplex Conjunctivitis
What Trends Are Shaping The Eye Infections Market?
In the eye infection market, leading businesses are concentrating on creating novel treatments like photodynamic therapy to increase the effectiveness of the treatment and minimize side effects. Photodynamic therapy involves the use of a light-sensitive drug that, when activated by certain light wavelengths, targets and eliminates abnormal or infected cells. For instance, VisiRose Inc., a clinical-stage biotech company from the US, joined forces with Provectus Biopharmaceuticals Inc., another US pharmaceutical company, and Bascom Palmer Eye Institute, a US health center, in December 2024. They introduced Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a revolutionary, non-invasive potential treatment for infectious keratitis and other severe eye infections. RB PDAT is a promising response to the growing global concern of antimicrobial resistance (AMR), providing a wide-ranging solution for ocular treatment. This approach is designed to be safe, effective, and financially feasible, meeting the urgent need for new treatments in this domain.
Who Are the Key Players In The Eye Infections Market?
Major companies operating in the eye infections market are:
• Pfizer Inc
• F. Hoffmann-La Roche AG
• Merck And Co Inc
• AbbVie Inc.
• Abbott Laboratories
• Novartis AG
• Takeda Pharmaceutical Company Limited
• Essilor International S.A.
• Teva Pharmaceutical Industries Limited
• Otsuka Pharmaceutical Co Ltd
• Regeneron Pharmaceuticals Inc
• Alcon Laboratories Inc.
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Limited
• Carl Zeiss Meditec AG
• Santen Pharmaceuticals Co Ltd
• Rohto Pharmaceutical Co Ltd
• Topcon Corporation
• Akorn Pharmaceuticals
• Alembic Pharmaceuticals Limited
• Novaliq GmbH
• Eyevance Pharmaceuticals LLC
• Ocular Therapeutix
• I-Med Pharma Inc.
• EyeGate Pharmaceuticals Inc
What Are The Regional Insights Into The Eye Infections Market?
North America was the largest region in the eye infections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.